WHO Expert Committee on Biological Standardization : sixty-third report. /
محفوظ في:
| مؤلف مشترك: | |
|---|---|
| التنسيق: | الكتروني كتاب الكتروني |
| اللغة: | الإنجليزية |
| منشور في: |
Geneva, Switzerland :
World Health Organization,
2014.
|
| سلاسل: | Technical report series (World Health Organization) ;
980. |
| الموضوعات: | |
| الوصول للمادة أونلاين: | An electronic book accessible through the World Wide Web; click to view |
| الوسوم: |
إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|
مواد مشابهة
WHO Expert Committee on Biological Standardization : sixty-third report. /
منشور في: (2014)
منشور في: (2014)
Who Expert Committee on Biological Standardization : sixty-second report.
منشور في: (2013)
منشور في: (2013)
Who Expert Committee on Biological Standardization : sixty-second report.
منشور في: (2013)
منشور في: (2013)
WHO Expert Committee on Biological Standardization : sixtieth report /
منشور في: (2013)
منشور في: (2013)
WHO Expert Committee on Biological Standardization : sixtieth report /
منشور في: (2013)
منشور في: (2013)
WHO Expert Committee on Biological Standardization fifty-sixth report.
منشور في: (2007)
منشور في: (2007)
WHO Expert Committee on Biological Standardization fifty-sixth report.
منشور في: (2007)
منشور في: (2007)
WHO Expert Committee on Biological Standardization : sixty-first report.
منشور في: (2013)
منشور في: (2013)
WHO Expert Committee on Biological Standardization : sixty-first report.
منشور في: (2013)
منشور في: (2013)
WHO Expert Committee on Biological Standardization fifty-second report.
منشور في: (2004)
منشور في: (2004)
WHO Expert Committee on Biological Standardization fifty-fourth report.
منشور في: (2005)
منشور في: (2005)
WHO Expert Committee on Biological Standardization fifty-fourth report.
منشور في: (2005)
منشور في: (2005)
WHO Expert Committee on Biological Standardization fifty-second report.
منشور في: (2004)
منشور في: (2004)
WHO Expert Committee on Specifications for Pharmaceutical Preparations forty-first report.
منشور في: (2007)
منشور في: (2007)
WHO Expert Committee on Specifications for Pharmaceutical Preparations forty-first report.
منشور في: (2007)
منشور في: (2007)
WHO Expert Committee on Specification for Pharmaceutical Preparations forty-second report.
منشور في: (2008)
منشور في: (2008)
WHO Expert Committee on Specification for Pharmaceutical Preparations forty-second report.
منشور في: (2008)
منشور في: (2008)
The selection and use of essential medicines
منشور في: (2006)
منشور في: (2006)
The selection and use of essential medicines
منشور في: (2006)
منشور في: (2006)
WHO Expert Committee on Specifications for Pharmaceutical Preparations : forty-eighth meeting report /
منشور في: (2014)
منشور في: (2014)
WHO Expert Committee on Specifications for Pharmaceutical Preparations : forty-eighth meeting report /
منشور في: (2014)
منشور في: (2014)
WHO Expert Committee on Specifications for Pharmaceutical Preparations fortieth report.
منشور في: (2006)
منشور في: (2006)
WHO Expert Committee on Specifications for Pharmaceutical Preparations fortieth report.
منشور في: (2006)
منشور في: (2006)
WHO Expert Committee on Specifications for Pharmaceutical Preparations thirty-ninth report.
منشور في: (2005)
منشور في: (2005)
WHO Expert Committee on Specifications for Pharmaceutical Preparations thirty-ninth report.
منشور في: (2005)
منشور في: (2005)
WHO Expert Committee on Specifications for Pharmaceutical Preparations thirty-seventh report.
منشور في: (2003)
منشور في: (2003)
WHO Expert Committee on Specifications for Pharmaceutical Preparations thirty-seventh report.
منشور في: (2003)
منشور في: (2003)
Good manufacturing practices for pharmaceuticals a plan for total quality control from manufacturer to consumer /
حسب: Willig, Sidney H., 1919-
منشور في: (2000)
حسب: Willig, Sidney H., 1919-
منشور في: (2000)
Good manufacturing practices for pharmaceuticals a plan for total quality control from manufacturer to consumer /
حسب: Willig, Sidney H., 1919-
منشور في: (2000)
حسب: Willig, Sidney H., 1919-
منشور في: (2000)
Rift-lines within European regulatory framework for biosimilars when taking heterogeneity and variation during lifecycle of the reference biologic and the biosimilar into account /
حسب: Osmane, Malik
منشور في: (2014)
حسب: Osmane, Malik
منشور في: (2014)
Rift-lines within European regulatory framework for biosimilars when taking heterogeneity and variation during lifecycle of the reference biologic and the biosimilar into account /
حسب: Osmane, Malik
منشور في: (2014)
حسب: Osmane, Malik
منشور في: (2014)
The selection and use of essential medicines report of the WHO Expert Committee, 2002.
منشور في: (2003)
منشور في: (2003)
The selection and use of essential medicines report of the WHO Expert Committee, 2002.
منشور في: (2003)
منشور في: (2003)
Standardization studies from the Germanic languages /
منشور في: (2002)
منشور في: (2002)
Standardization studies from the Germanic languages /
منشور في: (2002)
منشور في: (2002)
The selection and use of essential medicines report of the WHO Expert Committee, 2003 ; (including the 13th Model List of Essential Medicines).
منشور في: (2004)
منشور في: (2004)
The selection and use of essential medicines report of the WHO Expert Committee, 2003 ; (including the 13th Model List of Essential Medicines).
منشور في: (2004)
منشور في: (2004)
IFLA cataloguing principles steps towards an international cataloguing code, 3 : report from the 3rd IFLA Meeting of Experts on an International Cataloguing Code, Cairo, Egypt, 2005 /
منشور في: (2006)
منشور في: (2006)
IFLA cataloguing principles steps towards an international cataloguing code, 4 : report from the 4th IFLA Meeting of Experts on an International Cataloguing Code, Seoul, Korea, 2006 /
منشور في: (2007)
منشور في: (2007)
IFLA cataloguing principles steps towards an international cataloguing code, 4 : report from the 4th IFLA Meeting of Experts on an International Cataloguing Code, Seoul, Korea, 2006 /
منشور في: (2007)
منشور في: (2007)